In this article we will review the role of RIP140 in tissues relevant to the appearance and progression of the metabolic syndrome and discuss how the manipulation of RIP140 levels or activity might represent a therapeutic approach to combat obesity and associated metabolic disorders. The gene discussed is NRIP1; the disease is obesity due to melanocortin 4 receptor deficiency.